Trial Profile
Efficacy and safety of minodronate in the treatment of glucocorticoid-induced osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Oct 2013
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary)
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- 02 Oct 2013 New trial record